300119 瑞普生物
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资458,4641.11%453,446377,491275,062222,775
投资性房地产39,460-4.81%41,45646,98551,10973,585
固定资产1,834,58318.56%1,547,4291,188,035798,817735,217
在建工程100,75814.72%87,831373,747379,191379,746
无形资产505,618112.14%238,339258,537245,670249,497
商誉312,239360.51%67,80367,80367,80367,803
其他非流动资产869,737-2.96%896,310700,385811,442565,816
4,120,85823.65%3,332,6143,012,9822,629,0942,294,439

流动资产
货币资金387,17715.44%335,401384,4211,310,111294,467
应收账款992,9055.31%942,882742,527572,869442,975
存货393,5810.94%389,932367,056360,468364,009
其他流动资产1,301,315-18.42%1,595,1141,599,288818,240503,352
3,074,979-5.77%3,263,3283,093,2923,061,6881,604,803

流动负债
短期借款696,39930.45%533,832666,706591,114402,143
应付票据114,971-39.36%189,59168,44460,25620,144
应付帐款352,840-5.25%372,382328,981221,191187,891
其他流动负债539,475116.57%249,099245,644251,221267,053
1,703,68626.68%1,344,9051,309,7761,123,783877,231
流动资产净值1,371,294-28.52%1,918,4221,783,5161,937,905727,571
资产总额减流动负债5,492,1514.59%5,251,0364,796,4984,566,9993,022,010

非流动负债
长期借款424,51738.23%307,115191,18490,13598,135
应付债券0--0000
其他非流动负债184,66132.82%139,035104,214153,218186,846
609,17836.54%446,150295,398243,353284,981

总权益
    实收股本466,2760.00%466,276468,019468,344404,493
    储备项目3,997,405-0.81%4,030,0283,753,4873,564,3122,051,079
股东权益4,463,681-0.73%4,496,3044,221,5064,032,6562,455,572
非控股权益419,29335.88%308,582279,594290,991281,457